🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

European stocks drop on Spain downgrade; DAX falls 0.69%

Published 03/10/2011, 04:51 AM
NDX
-
UK100
-
FCHI
-
DJI
-
DE40
-
STOXX50
-
BBVA
-
SAN
-
ABDN
-
RIO
-
GSK
-
BHPB
-
ARM
-
SI
-
FRES
-
2070
-
FTNMX551030
-
Investing.com – European stock markets were broadly lower on Thursday, after Moody’s downgraded Spain’s government-bond rating, while U.S. futures indexes pointed to a downbeat open on Wall Street.

During European morning trade, the EURO STOXX 50 dropped 0.74%, France’s CAC 40 slumped 0.68%, while Germany's DAX fell 0.69%.

Earlier in the day, Moody’s downgraded Spain’s government-bond rating by one notch to Aa2 from Aa1 and assigned it a negative outlook, saying the country’s bank restructuring will cost more than the government currently expects, “leading to a further increase in the public-debt ratio.”
 
Following the news, Spain’s largest lender Banco Santander saw shares drop 2%, rival BBVA saw shares drop 1.8%, while Italy’s biggest bank Unicredit slumped 1.45%.

Meanwhile, shares in chip manufacturers performed poorly after the world’s second largest chip maker Texas Instruments lowered its current-quarter earnings outlook on Wednesday, citing weaker-than-expected demand for chips used in personal computers. 

Europe’s largest chip producer STMicroelectronics saw shares slide 2.8%, Infineon Technologies dropped 2%, while ARM Holdings saw shares plunge 6.9%.

In London, the commodity heavy FTSE 100 declined 0.73% with miners leading losses after metal prices retreated.

The world’s largest mining group BHP Billiton saw shares drop 2.9%, shares in rival Rio Tinto lost 3.1%, while silver producer Fresnillo saw shares tumble 3.3%.

Meanwhile, shares in Scotland’s largest insurance and investment group Standard Life plunged 4.6% after it reported 2010 earnings results that fell short of market expectations.

However, shares in pharmaceutical giant GlaxoSmithKline added 1.5% after the U.S. Food and Drug Administration approved its new drug to treat lupus.

The outlook for U.S. equity markets, meanwhile, was downbeat. The Dow Jones Industrial Average futures pointed to a drop of 0.36%, S&P 500 futures indicated a loss 0.49%, while the Nasdaq 100 futures slumped 0.68%.

Later in the day, the U.S. was to publish a key weekly report on initial jobless claims as well as data on the country’s trade balance.


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.